Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

• O. Fernández ,

  * E-mail: oscar.fernandez.sspa@gmail.com

  Affiliation Hospitales Universitarios Regional de Málaga y Virgen de la Victoria, Universidad de Málaga, IBIMA

  ⨯
• R. Arroyo,

  Affiliation Hospital U. Clínico San Carlos, Madrid

  ⨯
• S. Martínez-Yélamos,

  Affiliation Hospital Universitario de Bellvitge, Barcelona

  ⨯
• M. Marco,

  Affiliation Corporació Sanitaria Parc Taulí, Barcelona

  ⨯
• J. A. García Merino,

  Affiliation Hospital Universitario Puerta de Hierro, Madrid

  ⨯
• D. Muñoz,

  Affiliation Hospital Xeral Cies, Vigo

  ⨯
• E. Merino,

  Affiliation Departamento Médico, Merck S.L

  ⨯
• A. Roque,

  Affiliation Departamento Médico, Merck S.L

  ⨯
• RELOAD Study Group

  ¶Membership of the RELOAD Study Group is provided in the Acknowledgments.

  ⨯